Publications by authors named "Shamaki Garba"

2 Publications

  • Page 1 of 1

Peripheral Artery Disease: A Comprehensive Updated Review.

Curr Probl Cardiol 2021 Dec 11:101082. Epub 2021 Dec 11.

Department of Cardiology, Montefiore Medical Centre, NY. Electronic address:

Peripheral arterial disease is estimated to affect more than 200 million people worldwide. Although more than 50% of those affected are asymptomatic, it accounts for 3%-4% of amputations and a crude 5-year death rate of 82.4 deaths per 1000 patient-years when adjusted for duration of follow-up. Additionally, peripheral artery disease is often an indicator of obstructive atherosclerotic disease involvement of cerebral and coronary vessels, consequently increasing the risk of stroke, cardiovascular death, and myocardial infarction in these patient populations. The management of peripheral arterial disease includes conservative therapies, pharmacological treatments, interventional and surgical revascularization of blood vessels. Percutaneous transluminal angioplasty with balloons and stents has improved clinical outcomes compared to medical treatment alone. Despite these advances, the prevalence of peripheral arterial disease remains high. This review article aims to provide focused, up-to-date information on the clinical course, diagnosis, medical and interventional approach of the management of peripheral artery disease.
View Article and Find Full Text PDF

Download full-text PDF

Source Listing
December 2021

Structural Heart Interventions During COVID-19.

Curr Probl Cardiol 2022 Feb 24;47(2):100934. Epub 2021 Jul 24.

Department of Cardiology, Ochsner Medical Center, New Orleans, LA; Department of Cardiology, Albert Einstein University, Montefiore Medical Center, Bronx, NY.

The spread of Coronavirus Disease 2019 (COVID-19) pandemic across the globe and the United States presented unprecedented challenges with dawn of new policies to reserve resources and protect the public. One of the major policies adopted by hospitals across the nations were postponement of non-emergent procedures such as transaortic valve replacement (TAVR), left atrial appendage closure device (LAAC), MitraClip and CardioMEMS. Guidelines were based mainly on the avoidable clinical outcomes occurring during COVID-19 era. As our understanding of the SARS-CoV-2 evolved, advanced cardiac procedures may safely continue through careful advanced coordination. We aim to highlight the new guidelines published by different major cardiovascular societies, and discuss solutions to safely perform procedures to improve outcomes in a patient population with high acuity of illness during the COVID-19 pandemic era.
View Article and Find Full Text PDF

Download full-text PDF

Source Listing
February 2022